Exchange transfusion and pre‐filter apheresis dilution for hyperviscosity syndrome refractory to conventional therapeutic plasma exchange in a patient with IgA multiple myeloma

Documenti analoghi

• Characterization of the alcohol biomarker phosphatidylethanol in donor whole blood and apheresis red blood cells: Implications for transfusion recipients
  di: Theresa N. Kinard, et al.
  Pubblicazione: (2024)
• Beyond lipids: Systemic effects of lipoprotein apheresis
  di: Menatalla Nadim, et al.
  Pubblicazione: (2026)
• Clinical application of a modified platelet desialylation test for mechanistic characterization of platelet transfusion refractoriness
  di: Karen Ziza, et al.
  Pubblicazione: (2026)
• Management of human leukocyte antigen‐mediated platelet transfusion refractoriness: Brief synopsis and recent literature review
  di: Sandhya R. Panch, et al.
  Pubblicazione: (2024)
• Determining a safe pre‐transfusion protocol for multiple myeloma patients on anti‐ CD38 treatment
  di: Amanda Nicolson, et al.
  Pubblicazione: (2025)